Business Standard

Continue hydroxychloroquine as preventive therapy against Covid-19: ICMR

So far, only high-risk individuals, including asymptomatic health care workers, were given the drug along with household contacts of Covid patients

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
Premium

The conclusion has been drawn after three studies by the ICMR, and as result, it issued an advisory to expand the use of HCQ as a preventive therapy.

Sohini Das Mumbai
While a global debate rages around the efficacy and safety of hydroxychloroquine (HCQ) as a preventive therapy against coronavirus, India’s apex health research body, the Indian Council of Medical Research (ICMR), has found that consuming HCQ reduces the chances of getting infected with Covid-19.

The conclusion has been drawn after three studies by the ICMR, and as result, it issued an advisory to expand the use of HCQ as a preventive therapy.

The joint monitoring group, under the chairmanship of Director General of Health Services (DGHS), and including representatives from the All India Institute of Medical Sciences (AIIMS), ICMR, National

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 23 2020 | 11:05 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com